Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)

Author(s):
Dougados, M.; Kissel, K.; Sheeran, T.; Tak, P.P.; Conaghan, P.G.; Mola, E.M.; Schett, G.; Amital, H.; Navarro-Sarabia, F.; Hou, A.; Bernasconi, C.; Huizinga, T.W.J. (0000-0001-7033-7520)
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-01-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2013), Vol. 72, no. 1, p. 43-50
hdl
1887/98431
doi
10.1136/annrheumdis-2011-201282